Orbimed Advisors reduced stake in Oric Pharmaceuticals, Inc.

© Reuters. Orbimed Advisors reduced stake in Oric Pharmaceuticals, Inc. On the 24th of March, Orbimed Advisors sold 112 thousand Oric Pharmaceuticals, Inc. (ORIC) shares for $ 2.8 million at an average price of $ 24.53 per share. Shares of Oric Pharmaceuticals, Inc. are up 17.58% since the transaction. Orbimed Advisors’s holding in Oric Pharmaceuticals, […]

Continue Reading

Orbimed Advisors established new holdings in Graybug Vision, Inc.

© Reuters. Orbimed Advisors established new holdings in Graybug Vision, Inc. On the 25th of September, Orbimed Advisors purchased 563 thousand Graybug Vision, Inc. (GRAY) shares for $ 9 million at an average price of $ 16.00 per share. Shares of Graybug Vision, Inc. are down -1.21% since the transaction. Orbimed Advisors’s holding in Graybug […]

Continue Reading